30 Publications (Page 1 of 2)
2013
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin
Quinney, Sara KMalireddy, Srikar RVuppalanchi, RajHamman, Mitchell AChalasani, NagaGorski, J. C and Hall, Stephen D
European Journal of Clinical Pharmacology, vol. 69, (no. 3), pp. 439-48, Mar 2013. | Journal Article
 
The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.
Topletz, Ariel RDennison, Jennifer BBarbuch, Robert JHadden, Chad EHall, Stephen D and Renbarger, Jamie L
Drug metabolism and disposition: the biological fate of chemicals, vol. 41, (no. 9), pp. 1651-61, 2013/Sep. | Journal Article
2012
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.
Duke, Jon DHan, XuWang, ZhipingSubhadarshini, AbhinitaKarnik, Shreyas DLi, XiaochunHall, Stephen DJin, YanCallaghan, J TOverhage, Marcus JFlockhart, David AStrother, R MQuinney, Sara K and Li, Lang
PLoS computational biology, vol. 8, (no. 8), pp. e1002614, 2012. | Journal Article
2011
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
Egbelakin, AkinbodeEgbelakin, AkinbodeFerguson, Michael JFerguson, Michael JMacGill, Emily AMacGill, Emily ALehmann, Amalia SLehmann, Amalia STopletz, Ariel RTopletz, Ariel RQuinney, Sara KQuinney, Sara KLi, LangLi, LangMcCammack, Kevin CMcCammack, Kevin CHall, Stephen DHall, Stephen DRenbarger, Jamie L and Renbarger, Jamie L
Pediatric Blood & Cancer, vol. 56, (no. 3), pp. 361-367, 2011. | Journal Article
2008
A Bayesian Meta-Analysis on Published Sample Mean and Variance Pharmacokinetic Data with Application to Drug-Drug Interaction Prediction
Yu, MenggangKim, SeonghoWang, ZhipingHall, Stephen D and Li, Lang
Journal of Biopharmaceutical Statistics, vol. 18, (no. 6), pp. 1063-1083, 2008. | Journal Article
 
Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients
Renbarger, Jamie LMcCammack, Kevin CRouse, Caroline E and Hall, Stephen D
Pediatric Blood & Cancer, vol. 50, (no. 4), pp. 769-771, 2008. | Journal Article
2007
Computational approaches that predict metabolic intermediate complex formation with CYP3A4 (+b5).
Jones, David REkins, SeanLi, Lang and Hall, Stephen D
Drug metabolism and disposition: the biological fate of chemicals, vol. 35, (no. 9), pp. 1466-75, 2007/Sep. | Journal Article
 
Drug-drug interaction prediction: a Bayesian meta-analysis approach.
Li, LangYu, MenggangChin, RaymondLucksiri, AroonrutFlockhart, David A and Hall, Stephen D
Statistics in medicine, vol. 26, (no. 20), pp. 3700-21, 2007/Sep/10. | Journal Article
 
Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.
Dennison, Jennifer BJones, David RRenbarger, Jamie L and Hall, Stephen D
The Journal of pharmacology and experimental therapeutics, vol. 321, (no. 2), pp. 553-63, 2007/May. | Journal Article
2005
Association between the CYP3A5 genotype and blood pressure.
Ho, HerbertPinto, AmarHall, Stephen DFlockhart, David ALi, LangSkaar, Todd CCadman, PeterO'connor, Daniel TWagner, UrbanFineberg, Naomi S and Weinberger, Myron H
Hypertension, vol. 45, (no. 2), pp. 294-8, 2005/Feb. | Journal Article
 
Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein
Pinto, AGHorlander, J.Chalasani, N.Hamman, M.Asghar, A.Kolwankar, D. and Hall, Stephen D
British Journal of Clinical Pharmacology, vol. 59, (no. 4), pp. 440-446, 2005. | Journal Article
2004
Drug interactions with herbal products and grapefruit juice: a conference report.
Huang, Shiew-MeiHall, Stephen DWatkins, PaulLove, Lori ASerabjit-Singh, CosetteBetz, Joseph MHoffman, Freddie AHonig, PeterCoates, Paul MBull, JoncaChen, Shaw TKearns, Gregory L and Murray, Michael D
Clinical pharmacology and therapeutics, vol. 75, (no. 1), pp. 1-12, 2004/Jan. | Journal Article
 
The effect of anesthesia and surgery on CYP3A activity in rats.
Uhing, Michael RBeno, David WJiyamapa-Serna, Vanida AChen, YongGalinsky, Raymond EHall, Stephen D and Kimura, Robert E
Drug metabolism and disposition: the biological fate of chemicals, vol. 32, (no. 11), pp. 1325-30, 2004/Nov. | Journal Article
2003
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
Wang, ZaiqiHall, Stephen DMaya, Juan FLi, LangAsghar, Ali and Gorski, J C
British journal of clinical pharmacology, vol. 55, (no. 1), pp. 77-85, 2003/Jan. | Journal Article
 
The interaction between St John's wort and an oral contraceptive.
Hall, Stephen DWang, ZaiqiHuang, Shiew-MeiHamman, Mitchell AVasavada, NinaAdigun, Adegboyega QHilligoss, Janna KMiller, Margaret and Gorski, J C
Clinical pharmacology and therapeutics. , vol. 74, (no. 6), pp. 525-35, 2003/Dec. | Journal Article
2002
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Williams, J ARing, Barbara JCantrell, Varon EJones, David REckstein, JamesRuterbories, KennethHamman, Mitchell AHall, Stephen D and Wrighton, Steven A
Drug metabolism and disposition: the biological fate of chemicals, vol. 30, (no. 8), pp. 883-91, 2002/Aug. | Journal Article
 
Effect of St John's wort on the pharmacokinetics of fexofenadine.
Wang, ZaiqiHamman, Mitchell AHuang, Shiew-MeiLesko, Lawrence J and Hall, Stephen D
Clinical pharmacology and therapeutics, vol. 71, (no. 6), pp. 414-20, 2002/Jun. | Journal Article
 
KB-R7943 prevents acute, atrial fibrillation-induced shortening of atrial refractoriness in anesthetized dogs
Miyata, AkiraZipes, Douglas PHall, Stephen D and Rubart, Michael
Circulation, vol. 106, (no. 11), pp. 1410-9, Sep 10, 2002. | Journal Article
 
Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites.
Zhao, Xue-JunJones, David RWang, Ying-HongGrimm, S W and Hall, Stephen D
Xenobiotica; the fate of foreign compounds in biological systems, vol. 32, (no. 10), pp. 863-78, 2002/Oct. | Journal Article
 
The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition.
Shaw, Andrew AHall, Stephen DFranklin, Michael R and Galinsky, Raymond E
Drug metabolism and disposition: the biological fate of chemicals, vol. 30, (no. 2), pp. 177-82, 2002/Feb. | Journal Article
2001
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
Chalasani, NChalasani, NagaGorski, J.ChristopherGorski, J. CPatel, Nilesh HPatel, N HHall, Stephen DHall, Stephen DGalinsky, Raymond E and Galinsky, Raymond E
Hepatology (Baltimore, Md.), vol. 34, (no. 6), pp. 1103-8, 2001/Dec. | Journal Article
 
In vivo effect of clarithromycin on multiple cytochrome P450s.
Bruce, M AHall, Stephen DHaehner-Daniels, B D and Gorski, J C
Drug metabolism and disposition: the biological fate of chemicals, vol. 29, (no. 7), pp. 1023-8, 2001/Jul. | Journal Article
 
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
Kuehl, PeterKuehl, PeterZhang, JiongZhang, JiongLin, YvonneLin, YvonneLamba, Jatinder KLamba, JatinderAssem, MahfoudSchuetz, JohnSchuetz, John DWatkins, PaulWatkins, Paul BDaly, Ann KDaly, AnnWrighton, Steven AWrighton, Steven AHall, Stephen DHall, Stephen DMaurel, PatrickMaurel, PatrickRelling, Mary VRelling, MaryBrimer, CynthiaBrimer, CynthiaYasuda, KazutoYasuda, KazutoVenkataramanan, RamanVenkataramanan, RamanStrom, StephenStrom, Stephen CThummel, Kenneth EBoguski, Mark S and Schuetz, Erin G
Nature Genetics, vol. 27, (no. 4), pp. 383-391, 2001. | Journal Article
 
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.
Zhang, JKuehl, PGreen, Eric DTouchman, Jeffrey WWatkins, PaulDaly, Ann KHall, Stephen DMaurel, PRelling, MBrimer, CYasuda, KWrighton, S AHancock, MKim, Richard BStrom, SThummel, KRussell, C GHudson, J RSchuetz, Erin G and Boguski, M S
Pharmacogenetics, vol. 11, (no. 7), pp. 555-72, 2001/Oct. | Journal Article
2000
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.
Mayhew, B SJones, David R and Hall, Stephen D
Drug metabolism and disposition: the biological fate of chemicals, vol. 28, (no. 9), pp. 1031-7, 2000/Sep. | Journal Article